IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. - Wikidata - awgldk - TriplyDB

IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.

IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.

http://www.wikidata.org/entity/Q46839458

about

A microsatellite polymorphism in IGF1 gene promoter and longevity in a Han Chinese population.LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6 Consumption of sweet foods and breast cancer risk: a case-control study of women on Long Island, New York.Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent.Insulin-like growth factor 1 gene polymorphism and breast cancer risk among arab omani women: a case-control study IGF-I CA19 repeat polymorphisms and cancer risk: a meta-analysis Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer IGF gene polymorphisms and breast cancer in African-American and Hispanic women.Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer.The mechanism of transactivation regulation due to polymorphic short tandem repeats (STRs) using IGF1 promoter as a model.Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk.Insulin-like Growth Factor 1 gene polymorphism and breast cancer risk.Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.Insulin-like growth factor-I gene polymorphism in acne vulgaris.Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis.IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.Mitochondrial D-loop and Cytochrome Oxidase C subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India

P2860

Q30978768-63EF6597-9241-49E1-93DB-4A927B95EACD Q33765893-2710D154-F291-40F4-9086-5A31E90FA0F9 Q33916825-9B450C6A-5B57-4D02-9F65-2F017AA697E7 Q33945266-9483521B-9DA6-4CA4-8306-51913F983B79 Q34328099-728297C8-2095-4B47-889E-DAF3062B45B2 Q34673597-8875D070-2FE7-459A-B8ED-A2E72837A7F1 Q35186243-34434644-5268-4A5C-B1AB-A5C22582F916 Q35524233-43040F51-2311-4244-B52F-1DFE0D26562D Q36111455-2E2492AB-93F3-49B0-9906-73AC2A0FCF7A Q36492797-E916416B-50CB-473E-A4C5-5D9FE1BAA987 Q36609959-2F87F0F3-D4A2-49EB-BE28-A4A21351BF4E Q36931333-68B424F0-CC58-487A-9431-5EC7110A9387 Q37095826-B6750AC8-BB47-4976-B80E-BB8E980F2335 Q37098102-476CDFD3-A97B-44A2-95F3-DD6407636673 Q37107600-312A2C24-3858-4349-9367-5CCA6256C0AB Q37212940-CB13047A-7E86-474B-89E3-5A7349D03933 Q37464766-E4E27E2C-A34E-4E46-A3CA-37A5C4119A2E Q37467266-D97D61EB-2789-4C6A-8CEA-40C0EA969033 Q38169087-EF081CDD-E84A-4070-9825-2C038E98B58B Q38800155-459F19F4-E90F-4E07-90BF-61B5656C53AA Q39031223-42CA954A-2A88-4956-81C6-BCD479D4310B Q42375844-79F5C2E8-3312-4185-9710-F28657029C6D Q43486990-525DC122-2B94-4643-A969-9CDD6C430EC8 Q45944439-BC15970C-AD3D-4A66-8314-58B2DA88B236 Q46334218-FEC5BE30-BC60-45EA-B3E5-262898C405A0 Q47116282-412A9B6A-84A0-4D83-B59A-03DF4294D357 Q53081752-929FA505-BE94-49E2-980E-A172BC206C33 Q58984147-A4197C81-9299-4FB5-9B41-18DE1272062D

P2860

IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.

http://www.wikidata.org/entity/Q46839458

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@en

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@nl

type

label

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@en

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@nl

prefLabel

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@en

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@nl

P1433

Q46839458-D8441758-930D-4DFB-89EB-2BAE8DC81406

P1476

Q46839458-489F56F0-0077-4A19-BCFB-2F4414891F42

P2093

Q46839458-176A4A52-97D4-4303-BFB5-E95BE730354A

Q46839458-3105395C-B80E-4FDC-A62F-FAA49703B22B

Q46839458-594B27EF-E9D0-4FD0-A529-D77AC57D5689

Q46839458-7EB5F406-4DF7-4A8F-8AA9-C723499F15E0

Q46839458-83058CDD-C336-4731-9762-B263B1344367

Q46839458-8D307F24-55B2-4A40-B35D-26FB6AEFF7F0

Q46839458-A6AE1585-BA34-4CEE-8F45-E123CF291E3E

Q46839458-C62E8EDB-88DD-4125-AD64-9022CBD55CEA

Q46839458-CAC3F4AB-E2DC-4849-BFBE-9FF6515700B0

P2860

Q46839458-0AADB27B-245A-431B-A485-9F5559F340EA

Q46839458-0BEB72CB-1A09-4D81-B7AB-720D96E2CFA6

Q46839458-2B11641E-CCE9-41ED-A848-380985ADD3FA

Q46839458-2C279ABC-D1A9-4AC2-BD31-A7894F74186D

Q46839458-3C67E7AD-9DA3-4C48-87AD-4D60C7B4E530

Q46839458-3FD08198-4CDC-4F55-98B0-FB6D0470115C

Q46839458-44D6A16F-D3DA-46B5-A994-EFAE846E344C

Q46839458-4CB5D3D2-9AA7-4737-A418-F78E9C102A7D

Q46839458-5832A27F-2757-43D0-9A3C-256673CBD586

Q46839458-5EE3EBF4-F230-4B9D-9F02-D2CB4AE67EEF

P304

Q46839458-EE246ECC-177D-43FE-8374-EFE9F8B18345

P31

Q46839458-B9E33691-242A-4AD9-A36D-93AF60BE7F35

P356

Q46839458-0613856D-EA2D-4ECA-929C-0033AAA4330A

P407

Q46839458-F149CCE5-8EC6-4ABA-9C6C-04568FB3ED0C

P433

Q46839458-6CFBBE37-B229-45EB-91DE-1AC6EA3A7C9C

P478

Q46839458-77DDDAF4-742E-4F13-9F51-CDDF5019D247

P50

Q46839458-09CF68F7-1B82-479D-9F8B-66AA82D972A8

P577

Q46839458-2DEA4180-A780-4CBB-AE83-931A5028DAAC

P698

Q46839458-EDB537FA-96E6-46A9-9E27-621EBBB57BE2

P356

P1433

P1476

IGF1 CA repeat polymorphisms, ...... d Breast Cancer Study Project.

@en

P2093

Alfred I Neugut

http://www.w3.org/2001/XMLSchema#string

Julie A Britton

http://www.w3.org/2001/XMLSchema#string

Kathleen Conway

http://www.w3.org/2001/XMLSchema#string

Marilie D Gammon

http://www.w3.org/2001/XMLSchema#string

Rebecca J Cleveland

http://www.w3.org/2001/XMLSchema#string

Regina M Santella

http://www.w3.org/2001/XMLSchema#string

Sharon N Edmiston

http://www.w3.org/2001/XMLSchema#string

Susan L Teitelbaum

http://www.w3.org/2001/XMLSchema#string

Sybil M Eng

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

Molecular and cellular aspects of the insulin-like growth factor I receptor

Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

Growth hormone treatment induces mammary gland hyperplasia in aging primates.

IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.

Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6).

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer.

P304

758-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGI294

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Mary Beth Terry

P577

2005-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16332723

http://www.w3.org/2001/XMLSchema#string